Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster

Article

Applied Clinical Trials

Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.  

For more information, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.